Molecular diagnostics hub

MDx market analysis and updates

Large infrastructure investments in clinical laboratories since the covid-19 pandemic, along with rapid development of new diagnostic technologies are opening up new opportunities to enable personalised treatment, disease monitoring and improve patient outcomes for the world’s population through molecular diagnostics (MDx).

Clearstate offers market data, forecasts, and trend predictions to give you the insight to adjust your business strategy to meet the growing opportunities in molecular diagnostics. Our MDx hub is regularly updated to share our findings on this fast-growing diagnostic market segment.

Inquire now

What is molecular diagnostics (MDx)?

Molecular diagnostics (MDx) identify and quantify the presence of biomarkers or genetic material which are linked to different types of diseases. MDx tests are carried out at laboratories or other decentralised testing locations such as specialised departments within hospitals using molecular techniques such as PCR, real-time PCR (rtPCR), qPCR or sequencing.

Explore the latest MDx market insights

From market news to analysis, our articles provide concise and up-to-date information about the developments driving MDx market growth. Explore the latest in MDx technology and test applications from companion diagnostics to infectious disease screening as new solutions are developed and adopted in the market. Understand the implications of the emergence of MDx alternatives to traditional culture-based testing and immunoassays, and examine the issues that arise from growing competition in this segment of the market.

Covid-19: Three purchasing behaviour trends at molecular labs (Asia-Pacific)

Covid-19 has not only impacted test volumes but also spurred changes in test practices and purchasing behaviour in Asia-Pacific’s (APAC’s) molecular diagnostics (MDx) labs.

[On-demand Webinar] Covid-19 Impact: Molecular Diagnostic (MDx) Market

Clearstate zooms in on two of the fastest-growing molecular testing areas: cancer and covid-19 testing to uncover the market opportunities for IVD companies.

[On-demand webinar] will covid-19 accelerate the next wave of adoption of next-generation sequencing (NGS) in healthcare?

Sequencing-based diagnostic testing has been on the uptrend, with the adoption of next-generation sequencing (NGS) testing in oncology, genetics and prenatal screening – areas where the vast majority is done – continuing to grow strongly.

Rapid antigen tests to erode PCR-based molecular covid-19 test market in Asia-Pacific

Emergent covid-19 screening technologies coupled with declining testing demand are likely to erode the molecular-based covid-19 test market in Asia-Pacific (APAC) over the next five years.

Molecular diagnostics instrument sales in Asia-Pacific set to normalise as vaccination rates rise

Molecular diagnostics (MDx) instrument sales in Asia-Pacific (APAC) are expected to normalise in the next few years due to the high installed base, a result of government-mandated instrument purchases. These purchases caused a significant influx of new molecular analyser installations during the initial years of the pandemic.

Understand the molecular diagnostics market

Discover more IVD insights or learn how our IVD Gateway solution can help prepare your business for the future impact of the world’s expanding molecular diagnostic testing capacities.

Infectious diseases article by Clearstate

report by clearstate

Keeping ahead of infectious diseases in Asia-Pacific with increased testing

Our reports show how and where businesses can capture opportunities as laboratories adopt MDx across a wide range of applications.

Learn more

report by clearstate

The future of molecular diagnostics following the covid-19 crisis in Asia-Pacific

This report examines how the covid-19 pandemic has shifted the dynamics of molecular testing in APAC, as well as the future of the region’s MDx market. As molecular testing capabilities advance, will covid-19 related investments benefit other test areas?

Learn more

Clearstate newsletter

Sign up to our newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts.